¼¼°èÀÇ À̺ÎÇÁ·ÎÆæ ¿ø·áÀǾàǰ(API) ½ÃÀå(2025-2029³â)
Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2025-2029
»óǰÄÚµå : 1709724
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,443,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,508,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À̺ÎÇÁ·ÎÆæ ¿ø·áÀǾàǰ(API) ½ÃÀåÀº 2024-2029³â 2,738¸¸ 9,000´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È 2.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ À̺ÎÇÁ·ÎÆæ(Ibuprofen) ¿ø·áÀǾàǰ(API) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, ½ÃÀå ȯ°æ Àü¹Ý¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº °í·É Àα¸ Áõ°¡, ½ÅÈï±¹ÀÇ API Á¦Á¶ ½Ã³ª¸®¿À ¹ßÀü, Á¦¾à ¹× ¹ÙÀÌ¿À ÀǾàǰ »ý»ê Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ 2025³â
Á¾·á ¿¬µµ 2029³â
¿¹Ãø ±â°£ 2025-2029³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
YOY 2025 2.1%
CAGR 2.1%
Áõ°¡¾× 2,738¸¸ 9,000 ´Þ·¯

ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. º¸°í¼­¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ª ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼­¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÇâÈÄ ¸î ³â µ¿¾È À̺ÎÇÁ·ÎÆæ API ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ÀÌÀ¯ Áß Çϳª·Î API Á¦Á¶ ÆÐ·¯´ÙÀÓÀÇ º¯È­¸¦ ²Å°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À̺ÎÇÁ·ÎÆæ API Á¦Á¶¾÷üÀÇ R&D ÅõÀÚ Áõ°¡¿Í À̺ÎÇÁ·ÎÆæ API Á¦Á¶¸¦ À§ÇÑ CEP ½ÂÀÎ °Ç¼ö Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå Technavio ºÐ¼®

Á¦3Àå ½ÃÀå ±¸µµ

Á¦4Àå ½ÃÀå ±Ô¸ð

Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦6Àå Á¤¼º ºÐ¼®

Á¦7Àå Five Forces ºÐ¼®

Á¦8Àå ½ÃÀå ¼¼ºÐÈ­ : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ½ÃÀå ¼¼ºÐÈ­ : Á¦Ç°º°

Á¦10Àå °í°´ »óȲ

Á¦11Àå Áö¿ªº° »óȲ

Á¦12Àå ¼ºÀå, ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦13Àå °æÀï ±¸µµ

Á¦14Àå °æÀï ºÐ¼®

Á¦15Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The ibuprofen active pharmaceutical ingredient (API) market is forecasted to grow by USD 27389 thousand during 2024-2029, accelerating at a CAGR of 2.1% during the forecast period. The report on the ibuprofen active pharmaceutical ingredient (API) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population, evolving api manufacturing scenario in developing countries, and increase in pharmaceutical and biopharmaceutical production.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20252.1%
CAGR2.1%
Incremental Value$27389 th

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's ibuprofen active pharmaceutical ingredient (API) market is segmented as below:

By End-user

By Product

By Geographical Landscape

This study identifies the paradigm shift in api manufacturing as one of the prime reasons driving the ibuprofen active pharmaceutical ingredient (API) market growth during the next few years. Also, increase in research and development investments by ibuprofen api manufacturers and increase number of cep approval for manufacture of ibuprofen api will lead to sizable demand in the market.

The report on the ibuprofen active pharmaceutical ingredient (API) market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ibuprofen active pharmaceutical ingredient (API) market vendors that include Arch Pharmalabs Ltd., Athos Chemicals Pvt. Ltd., Azelis SA, BASF SE, Chemino Pharma Ltd., Dr Reddys Laboratories Ltd., Granules India Ltd., HELM AG, IOL Chemicals and Pharmaceuticals Ltd., Mallinckrodt Plc, Octavius Pharma Pvt. Ltd., Otto Brandes GmbH, Piramal Enterprises Ltd., Rochem International Inc., SI Group Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd., Solara Active Pharma Sciences Ltd, Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., and Titan Lab Pvt Ltd.. Also, the ibuprofen active pharmaceutical ingredient (API) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by End-user

9 Market Segmentation by Product

10 Customer Landscape

11 Geographic Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â